These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4077290)

  • 1. Deranged Ca, Al and Mg content in the tissues of patients with chronic renal failure, as measured by non-destructive neutron activation analysis.
    Marumo F; Nakamura M; Sato N; Shimada H; Tsukamoto S; Iwanami S
    Int J Artif Organs; 1985 Nov; 8(6):319-24. PubMed ID: 4077290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Role of aluminium and magnesium effects on initiation and promotion of renal osteodystrophy in patients with chronic renal failure].
    Nakamrua M; Sato N; Tsukamoto Y; Marumo F; Iwanami S
    Nihon Jinzo Gakkai Shi; 1986 Apr; 28(4):421-8. PubMed ID: 3747253
    [No Abstract]   [Full Text] [Related]  

  • 3. Trace element concentrations in hair, fingernails and plasma of patients with chronic renal failure on hemodialysis and hemofiltration.
    Marumo F; Tsukamoto Y; Iwanami S; Kishimoto T; Yamagami S
    Nephron; 1984; 38(4):267-72. PubMed ID: 6514076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between hair, serum and bone aluminium in hemodialyzed patients.
    Chappuis P; de Vernejoul MC; Paolaggi F; Rousselet F
    Clin Chim Acta; 1989 Feb; 179(3):271-8. PubMed ID: 2714000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminium in bone from patients with renal failure.
    Parsons V; Davies C; Goode C; Ogg C; Siddiqui J
    Br Med J; 1971 Oct; 4(5782):273-5. PubMed ID: 5123910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The investigation and treatment of renal bone disease.
    Catto GR; MacLeod M
    Am J Med; 1976 Jul; 61(1):64-73. PubMed ID: 937372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal osteodystrophy in Maracaibo].
    Salgado O; García R; Delling G; Navarro J; Romero RA; Rodríguez-Iturbe B
    Invest Clin; 1992; 33(4):153-64. PubMed ID: 1303675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trace element concentrations in tissues of patients with chronic renal failure by non-destructive neutron activation analysis].
    Sato N; Nakamura M; Tsukamoto Y; Marumo F; Iwanami S
    Nihon Jinzo Gakkai Shi; 1986 Feb; 28(2):197-202. PubMed ID: 3735770
    [No Abstract]   [Full Text] [Related]  

  • 9. Scalp hair as an indicator of aluminium exposure: comparison to bone and plasma.
    Wilhelm M; Passlick J; Busch T; Szydlik M; Ohnesorge FK
    Hum Toxicol; 1989 Jan; 8(1):5-9. PubMed ID: 2785480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum-related bone disease in mild and advanced renal failure: evidence for high prevalence and morbidity and studies on etiology and diagnosis.
    Smith AJ; Faugère MC; Abreo K; Fanti P; Julian B; Malluche HH
    Am J Nephrol; 1986; 6(4):275-83. PubMed ID: 3777036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of trace elements in patients with chronic renal failure by neutron activation analysis.
    Tsukamoto Y; Iwanami S; Marumo F
    Proc Eur Dial Transplant Assoc; 1979; 16():665-7. PubMed ID: 549006
    [No Abstract]   [Full Text] [Related]  

  • 12. Aluminium determination in the skin of patients with and without end-stage renal failure.
    Subra JF; Krari N; Tirot P; Mauras Y; Balit G; Van-Weydevelt FC; Allain P
    Nephron; 1991; 58(2):170-3. PubMed ID: 1865973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased bone strontium levels in hemodialysis patients with osteomalacia.
    D'Haese PC; Schrooten I; Goodman WG; Cabrera WE; Lamberts LV; Elseviers MM; Couttenye MM; De Broe ME
    Kidney Int; 2000 Mar; 57(3):1107-14. PubMed ID: 10720963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a technique to measure bone aluminium content using neutron activation analysis.
    Wyatt RM; Ryde SJ; Morgan WD; McNeil EA; Hainsworth IR; Williams AJ
    Physiol Meas; 1993 Aug; 14(3):327-35. PubMed ID: 8401272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnesium, calcium and trace elements distribution in serum, erythrocytes, and hair of patients with chronic renal failure.
    Długaszek M; Szopa M; Rzeszotarski J; Karbowiak P
    Magnes Res; 2008 Jun; 21(2):109-17. PubMed ID: 18705539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some applications of neutron activation for the analysis of human bone.
    Goode GC; Howard CM; Wilson AR; Parsons V
    Anal Chim Acta; 1972 Feb; 58(2):363-8. PubMed ID: 5014208
    [No Abstract]   [Full Text] [Related]  

  • 18. Aluminum accumulation in the skin in end-stage renal failure.
    Ichimaru K; Horie A
    Nephron; 1987; 46(3):239-42. PubMed ID: 3627317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hair trace elements in kidney dialysis patients by INAA.
    Jervis RE; Kua BT; Hercz G
    Biol Trace Elem Res; 1994; 43-45():335-42. PubMed ID: 7710846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.